linco-feed 110 mg/g premix for medicated feeding stuff
lavet pharmaceuticals ltd. - lincomycin 110 mg/g - premix for medicated feed - pigs - lincomycin
linco-feed 110 mg/g premix for medicated feeding stuff
lavet pharmaceuticals ltd. - lincomycin 110 mg/g - premix for medicated feed - pigs - lincomycin
abbeylinc premix
abbey laboratories pty ltd - lincomycin as lincomycin hydrochloride - oral powder, pre-mix - lincomycin as lincomycin hydrochloride antibiotic active 44.0 g/kg - antibiotic & related
lincomycin hydrochloride
abbey laboratories pty ltd - lincomycin hydrochloride - unknown - lincomycin hydrochloride antibiotic active 0.0 - active constituent
lincomycin hydrochloride
dox-al australia pty ltd - lincomycin hydrochloride - unknown - lincomycin hydrochloride antibiotic active 0.0 - active constituent
abbeylinc 300 injection
abbey laboratories pty ltd - lincomycin as lincomycin hydrochloride - parenteral liquid/solution/suspension - lincomycin as lincomycin hydrochloride antibiotic active 300.0 mg/ml - antibiotic & related
lincomycin injection 300mgml
y.s.p. industries (m) sdn. bhd. - lincomycin hcl -
lincorx 300 mg/ml
probus pharmaceuticals pty ltd - lincomycin as lincomycin hydrochloride - parenteral liquid/solution/suspension - lincomycin as lincomycin hydrochloride antibiotic active 300.0 mg/ml - antibiotic & related
lincomycin capsules bp 500 mg
63, westlands road, nairobi kenya 63, westlands road, nairobi kenya - lincomycin hydrochloride bp - capsule - 500mg/tablet - lincomycin
lincomycin-spectinomycin water soluble powder- lincomycin-spectinomycin powder, for solution
huvepharma, inc - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f), spectinomycin hydrochloride (unii: hwt06h303z) (spectinomycin - unii:93aki1u6qf) - directions for use indications and usage: for use in chickens up to 7 days of age as an aid in the control of: airsacculitis caused by either mycoplasma synoviae or mycoplasma gallisepticum susceptible to lincomycin-spectinomycin. complicated chronic respiratory disease (air sac infection) caused by escherichia coli and m. gallisepticum susceptible to lincomycin-spectinomycin. warning: not for human use keep out of reach of children to report suspected adverse drug events, for technical assistance or to obtain a copy of the safety data sheet (sds), contact huvepharma, inc. at 1-877-994-4883 or www.huvepharma.us. for additional information about adverse drug experience reporting for animal drugs, contact fda at 1-888-fda-vets or http://www.fda.gov/reportanimalae.